Advertisement
Journal Home
Search for

Issue

Free This issue is open to the public.

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

The American Journal of Medicine
Volume 122, Issue 6, Supplement (June 2009)
Search Within This Issue
Demystifying Incretin Therapy for Type 2 Diabetes
Edited by Vivian A. Fonseca MD
The publication of this supplement was supported by a grant from Novo Nordisk

display abstract citation download email a colleague
Display:


Title page
page i
Full Text | Full-Text PDF (36 KB)


Faculty List
page iv
Full Text | Full-Text PDF (23 KB)


Faculty Disclosures
page v
Full Text | Full-Text PDF (32 KB)


Introduction
Vivian A. Fonseca
pages S1-S2
Full Text | Full-Text PDF (99 KB)


Unraveling the Science of Incretin Biology
Michael A. Nauck
pages S3-S10
Abstract | Full Text | Full-Text PDF (644 KB)


Efficacy and Safety of Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
Matthew P. Gilbert, Richard E. Pratley
pages S11-S24
Abstract | Full Text | Full-Text PDF (507 KB)


Incretin Therapies: Effects Beyond Glycemic Control
Sunder Mudaliar, Robert R. Henry
pages S25-S36
Abstract | Full Text | Full-Text PDF (630 KB)


Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use
David M. Kendall, Robert M. Cuddihy, Richard M. Bergenstal
pages S37-S50
Abstract | Full Text | Full-Text PDF (1245 KB)

display abstract citation download email a colleague
Display:
Advertisement